RXRX - Recursion Pharmaceuticals, Inc.
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$8.25
DETAILS
HIGH:
$11.00
LOW:
$5.50
MEDIAN:
$8.25
CONSENSUS:
$8.25
UPSIDE:
174.09%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | -62.0% |
| EBIT Margin | -861.1% |
| EBITDA Margin | -749.0% |
| Operating Margin | -867.9% |
| Pretax Margin | -863.5% |
| Cont. Ops Margin | -863.4% |
| Net Margin | -863.4% |
| Bottom Line Margin | -863.4% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 5.50 |
| Quick Ratio | 5.50 |
| Solvency Ratio | -1.634 |
| Cash Ratio | 5.03 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings |
-2.84
Peers avg: 37.1
|
| PEG Ratio | 0.19 |
| Forward PEG | 0.19 |
| Price/Book | 1.62 |
| Price/Sales | 24.50 |
| Price/FCF | -4.84 |
| Price/Op Cash Flow | -4.92 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.0529 |
| Debt/Equity | 0.0689 |
| Debt/Capital | 0.0645 |
| Long-Term Debt/Capital | 0.0474 |
| Financial Leverage | 1.30 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 0.13 |
| Operating Cash Flow Ratio | -2.517 |
| Operating Cash Flow/Sales | -497.9% |
| Free Cash Flow/Operating Cash Flow | 101.7% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | -23.73 |
| Interest Coverage | -358.0840 |
| Short-Term Operating Cash Flow Coverage | -17.09 |
| Operating Cash Flow Coverage | -4.77 |
| Capital Expenditure Coverage | -57.48 |
| Dividend + Capital Expenditure Coverage | -57.48 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 0.17 |
| EPS | -1.441 |
| Debt/Share | 0.1783 |
| Cash/Share | 1.66 |
| Book Value/Share | 2.53 |
| Tangible BV/Share | 1.47 |
| Equity/Share | 2.53 |
| Operating Cash Flow/Share | -0.831 |
| Capital Expenditure/Share | 0.014 |
| FCF/Share | -0.845 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 1.000 |
| Earnings Before Tax/EBIT | 0.995 |
| Price/Fair Value | 1.62 |
| Debt/Market Cap | 0.0426 |
| Effective Tax Rate | 0.0% |
| Enterprise Value Multiple | -2.08 |